This report contains market size and forecasts of Anti-diabetic Medication in Global, including the following market information:
Global Anti-diabetic Medication Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Anti-diabetic Medication market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Oral Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Anti-diabetic Medication include Merck Sharp & Dohme, Lilly, Novo Nordisk, Huadong Medicine, Bayer, Oddway International, Luye and Uni-Bio Group, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Anti-diabetic Medication companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anti-diabetic Medication Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Anti-diabetic Medication Market Segment Percentages, by Type, 2021 (%)
Oral
Injection
Other
Global Anti-diabetic Medication Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Anti-diabetic Medication Market Segment Percentages, by Application, 2021 (%)
Prevent and Treatment Diabetes
Obesity Treatment
Cardiovascular Protection
Other
Global Anti-diabetic Medication Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Anti-diabetic Medication Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anti-diabetic Medication revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Anti-diabetic Medication revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck Sharp & Dohme
Lilly
Novo Nordisk
Huadong Medicine
Bayer
Oddway International
Luye
Uni-Bio Group